Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brumbaugh P. F., Haussler M. R. Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine. J Biol Chem. 1975 Feb 25;250(4):1588–1594. [PubMed] [Google Scholar]
- Colston K., Colston M. J., Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981 Mar;108(3):1083–1086. doi: 10.1210/endo-108-3-1083. [DOI] [PubMed] [Google Scholar]
- Frampton R. J., Suva L. J., Eisman J. A., Findlay D. M., Moore G. E., Moseley J. M., Martin T. J. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res. 1982 Mar;42(3):1116–1119. [PubMed] [Google Scholar]
- Fukushima M., Suzuki Y., Toira Y., Matsunaga I., Ochi K., Nagano H. Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver. Biochem Biophys Res Commun. 1975 Sep 16;66(2):632–638. doi: 10.1016/0006-291x(75)90556-2. [DOI] [PubMed] [Google Scholar]
- Honma Y., Hozumi M., Abe E., Konno K., Fukushima M., Hata S., Nishii Y., DeLuca H. F., Suda T. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A. 1983 Jan;80(1):201–204. doi: 10.1073/pnas.80.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato T., Takusagawa K., Asoo N., Konno K. Antitumor effect of 1 alpha-hydroxyvitamin D3. Tohoku J Exp Med. 1982 Dec;138(4):445–446. doi: 10.1620/tjem.138.445. [DOI] [PubMed] [Google Scholar]